Actavis PLC is in advanced talks to acquire rival drug maker Forest Laboratories Inc., in a deal that could value Forest at up to $25 billion, according to people familiar with the matter.

The deal is expected to be announced as early as Tuesday, the people said. It's possible the talks could still fall apart.

The proposed combination of...